The Doak Dermatologics subsidiary of Bradley Pharmaceuticals has an 80-year history of providing quality skincare therapies to specialty physician audiences. Serving both the dermatology and podiatry communities, Doak brands provide symptomatic relief for a wide range of patients suffering from uncomfortable and often chronic skin and nail conditions, including acne, rosacea, actinic keratosis, psoriasis, seborrheic dermatitis and pruritic conditions such as eczema and dermatitis.

Well-known Doak brands include SOLARAZE^® GEL, ADOXA^®, ROSULA^®, ZODERM^®, LIDAMANTLE^® and KEROL™.

Doak believes in furthering the study and practice of dermatology, and is therefore an active supporter of numerous professional medical organizations at the national and regional levels, as well as continuing education programs including seminars and symposia.

Nycomed US Inc. Acquires Bradley Pharmaceuticals
 

Copyright © 2007 Doak Dermatologics, a subsidiary of Bradley Pharmaceuticals Inc. All rights reserved.

 2007 Bradley Pharmaceuticals Inc. All rights reserved.

If you're interested in licensing or reselling Doak Dermatologics products in your country, please feel free to contact us. We offer exclusive licensing or reseller volume rates, depending on your marketing approach. Also, if you would like to distribute a localized version in your country, we'd be glad to assist you. Click here for more information.